Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus

Journal of Research in Medical Sciences

Volumn 16, Issue SPEC. ISSUE, 2011, Pages 412-418

  Srirama, Shanmugam ^a   Chacka, Lini Elizabeth ^a   Ramasamya, Rajeswari ^a   Ghasemia, Ali ^a   Ravia, Thengungal Kochupapy ^a   Sabzghabaee, Ali Mohammad ^b  

^a SRI RAMAKRISHNA INSTITUTE OF PARAMEDICAL SCIENCES   (India)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clinical pharmacy; Diabetes mellitus; Pharmaceutical care; Quality of life; South India

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIA; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT SATISFACTION; PHARMACEUTICAL CARE; PROSPECTIVE STUDY; QUALITY OF LIFE; STUDENT T TEST;

EID: 79955558750     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gulliford MC, Charlton J. Is relative mortality of type 2 diabetes mellitus decreasing? Am J Epidemiol 2009; 169(4): 455-61.
2. The global challenge of diabetes. Lancet. 2008; 371(9626): 1723.
3. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007; 125(3): 217-30.
4. Ramachandran A, Snehalatha C. Type 2 Diabetes Mellitus - The Epidemic of the 21st century: The Indian Scenario. Int J Diabetes Dev Countries 1999; 19: 158-64.
5. Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13(Suppl 1): 1-68.
6. Davis TM, Clifford RM, Davis WA, Batty KT. The role of pharmaceutical care in diabetes management. Br J Diabetes Vasc Dis 2005; 5(6): 352-6.
7. Indian Health Service Dodtap. Indian Health Diabetes Best Practices: Pharmaceutical Care and Diabetes. [cited 2010 Sep 10]; Available from http://www.ihs.gov/MedicalPrograms/Diabetes/.
8. Khan CR, Weir GC, King GL, Moses AC. Joselin's Diabetes Mellitus. 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
9. Polonsky WH. Understanding and assessing diabetes-specific quality of life. Diabetes Spectrum. 2000; 13(1): 36-41.
10. Hawkins D, Bradberry JC, Cziraky MJ, Talbert RL, Bartels DW, Cerveny JD. National Pharmacy Cardiovascular Council treatment guidelines for the management of type 2 diabetes mellitus: toward better patient outcomes and new roles for pharmacists. Pharmacotherapy 2002; 22(4): 436-44.
11. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999; 8(1-2): 79-91.
12. Wee HL, Tan CE, Goh SY, Li SC. Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) questionnaire in patients with diabetes in a multi-ethnic Asian country. Pharmacoeconomics 2006; 24(7): 673-82.
13. Soon SS, Goh SY, Bee YM, Poon JL, Li SC, Thumboo J, et al. Audit of Diabetes-Dependent Quality of Life (ADDQoL) [Chinese Version for Singapore] questionnaire: reliability and validity among Singaporeans with type 2 diabetes mellitus. Appl Health Econ Health Policy 2010; 8(4): 239-49.
14. Kamarul Imran M, Ismail AA, Naing L, Wan Mohamad WB. The reliability and validity of the Malay version of the 18-item audit of Diabetes Dependent Quality of Life (the Malay ADDQOL) questionnaire. Southeast Asian J Trop Med Public Health 2007; 38(2): 398-405.
15. Bradley C, Plowright R, Stewart J, Valentine J, Witthaus E. The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ. Health Qual Life Outcomes 2007; 5: 57.
16. Nicolucci A, Giorgino R, Cucinotta D, Zoppini G, Muggeo M, Squatrito S, et al. Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ). Diabetes Nutr Metab 2004; 17(4): 235-43.
17. Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian J Diabetes 2008; 32(Supplement 1): S1-S215.
18. Powell MF, Burkhart VD, Lamy PP. Diabetic patient compliance as a function of patient counseling. Drug Intell Clin Pharm 1979; 13(9): 506-11.
19. Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2005; 28(4): 771-6.
20. Cioffi ST, Caron MF, Kalus JS, Hill P, Buckley TE. Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic. Ann Pharmacother 2004; 38(5): 771-5.
21. Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother 2005; 39(3): 433-40.
22. Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci 2011; 16(1): 43-9.
23. Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Role of the pharmacist education in diabetes management in patients referring to Isfahan Endocrine and Metabolism Research Center. Pharm World Sci 2010; 32(5): 679-80.
24. Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Adherence to oral hypoglycemic medication in type 2 diabetic patients in Isfahan, Iran: prevalence and barriers to adherence. Pharm World Sci 2010; 32(5): 677.